Comparison Phathom Pharmaceuticals (PHAT) with Competitors
Phathom Pharmaceuticals (PHAT) industry is Biotechnology.
Profit Margin
PHAT-52.09%
Industry-0.77%
Upside-51.32%
Operating Margin
PHAT-26.55%
Industry-2055.25%
Upside+2028.70%
Debt-to-Equity
PHAT-48.57%
Industry28.27%
Upside-76.84%
Free Cash Flow Yield
PHAT-11.14%
Industry-1.75%
Upside-9.39%
P/E
PHAT-5.06
Industry-20.52
Upside+1545.24%
P/S
PHAT4.30
Industry10.01
Upside-57.05%
P/B
PHAT25.37
Industry5.15
Upside+392.93%